Krystal Biotech, Inc. · NASDAQ:KRYS
Thomas John Charles sold 642 Krystal Biotech, Inc. shares (Form 4)
Traded May 26, 2026 · Filed May 27, 2026
On May 26, 2026, Thomas John Charles (EVP, General Counsel) sold 642 Krystal Biotech, Inc. shares at US$302.03 for US$194K under a trading plan, leaving 0 shares. Filed May 27, 2026 (Form 4).
- Sold
- 642 shares
- Price
- US$302.03
- Value
- US$194K
- Holding after
- 0 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- EVP, General Counsel
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 26, 2026 | Common Stock | Sale | 642 | US$302.03 | 0 | Direct |
Source
Related
- Krystal Biotech, Inc.
- Thomas John Charles
- Krystal Biotech, Inc. shareholders
- Form 4 · Thomas John Charles · Jun 26, 2026
- Form 4 · Krishnan Suma · Sep 4, 2026
- Form 4 · Krishnan Krish S · Sep 4, 2026
- Form 4 · Rossi Dino A · Aug 14, 2026
- Form 4 · Krishnan Suma · Jun 5, 2026
- Schedule 13G/A · Krishnan Krish S · May 4, 2026